Benjamin Young

Summary

Publications

  1. doi Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, Colorado 80220, USA
    Clin Infect Dis 52:1061-8. 2011
  2. doi A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial
    Benjamin Young
    Rocky Mountain CARES, Denver, Colorado, USA Health Connections International, Amsterdam, The Netherlands
    HIV Clin Trials 11:260-9. 2010
  3. doi Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, CO, USA
    Antivir Ther 16:253-6. 2011
  4. doi Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study
    Kenneth A Lichtenstein
    National Jewish Medical and Research Center, Denver, Colorado 80206, USA
    Clin Infect Dis 51:435-47. 2010
  5. doi Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study
    Benjamin Young
    Denver Infectious Disease Consultants, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 23:589-92. 2009
  6. pmc Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES
    Benjamin Young
    Apex Family Medicine and Research, Denver, Colorado 80209, USA
    AIDS Res Hum Retroviruses 29:350-8. 2013
  7. ncbi Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Int Assoc Physicians AIDS Care (Chic) 6:178-87. 2007
  8. ncbi Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    AIDS Patient Care STDS 20:238-44. 2006
  9. ncbi The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 37:S13-20. 2004
  10. ncbi PA update: DHHS guidelines for the treatment of HIV infection
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    JAAPA . 2006

Detail Information

Publications14

  1. doi Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, Colorado 80220, USA
    Clin Infect Dis 52:1061-8. 2011
    ..Among persons with HIV infection, low bone mineral density is common and has raised concerns about increased risk of fracture...
  2. doi A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial
    Benjamin Young
    Rocky Mountain CARES, Denver, Colorado, USA Health Connections International, Amsterdam, The Netherlands
    HIV Clin Trials 11:260-9. 2010
    ..to evaluate raltegravir plus abacavir/lamivudine in antiretroviral-naïve, HIV-1-infected patients...
  3. doi Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy
    Benjamin Young
    Rocky Mountain CARES DIDC, Denver, CO, USA
    Antivir Ther 16:253-6. 2011
    ..This case illustrates an emerging need to consider the possibility of acquired INI resistance among newly diagnosed treatment-naive individuals harbouring multidrug-resistant HIV-1...
  4. doi Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study
    Kenneth A Lichtenstein
    National Jewish Medical and Research Center, Denver, Colorado 80206, USA
    Clin Infect Dis 51:435-47. 2010
    ..We investigated the association of low CD4(+) T lymphocyte cell count with incident CVD in a cohort of outpatients treated in 10 HIV specialty clinics in the United States...
  5. doi Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study
    Benjamin Young
    Denver Infectious Disease Consultants, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 23:589-92. 2009
    ....
  6. pmc Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES
    Benjamin Young
    Apex Family Medicine and Research, Denver, Colorado 80209, USA
    AIDS Res Hum Retroviruses 29:350-8. 2013
    ..Lp-PLA(2) median values declined significantly over 144 weeks for subjects in either FRS stratum...
  7. ncbi Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Int Assoc Physicians AIDS Care (Chic) 6:178-87. 2007
    ..Background: Cases of renal dysfunction have been reported in HIV-infected patients taking tenofovir (TDF), but few large studies have examined population-level changes in renal function associated with TDF use in patients in routine care...
  8. ncbi Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    AIDS Patient Care STDS 20:238-44. 2006
    ....
  9. ncbi The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 37:S13-20. 2004
    ..In an environment where several NRTI/NtRTI backbones offer comparable efficacy, treatment decisions will increasingly be made based on toxicity, resistance, and convenience considerations...
  10. ncbi PA update: DHHS guidelines for the treatment of HIV infection
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    JAAPA . 2006
  11. ncbi Review: mixing new cocktails: drug interactions in antiretroviral regimens
    Benjamin Young
    Rose Medical Center, Denver, Colorado 80220, USA
    AIDS Patient Care STDS 19:286-97. 2005
    ..The paper also addresses interactions between these antiretrovirals and other commonly used medications that may be prescribed concomitantly...
  12. doi First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
    Benjamin Young
    Division of General Internal Medicine, University of Colorado, Rose Medical Center, Denver, Colorado 80220, USA
    AIDS 22:1673-5. 2008
    ....
  13. ncbi Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults
    Benjamin Young
    Rose Medical Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 31:478-82. 2002
    ..In this study, twice-daily indinavir 800 mg/ritonavir 100 mg with two nucleoside reverse transcriptase inhibitors provided potent viral suppression and immunologic reconstitution in many PI-naive patients...
  14. doi Use of screening colonoscopy in ambulatory HIV-infected patients
    Jeffrey Campbell
    Rose Medical Center, University of Colorado, General Internal Medicine, Boulder, Colorado, USA
    J Int Assoc Physicians AIDS Care (Chic) 7:286-8. 2008
    ..Colorectal cancer screenings are underused in HIV-infected patients, but reasons for underuse have not been examined...